Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Vertex and Ironwood Drugs Fare Well in Clinical Trials, Pulmatrix Breathes in $30.2M, IRobot Launches Healthcare Unit, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
11/04/09 |
Boston
|
|
Combination Drugs Are The Future for Hepatitis C
|
Steve Worland |
11/03/09 |
San Diego
|
|
Vertex Hepatitis C Drug Passes Key Test With More Convenient, Twice-Daily Dose
|
Luke Timmerman |
10/31/09 |
Boston
|
|
Vertex Hepatitis C Drug Wipes Out Virus For Toughest-to-Treat Patients
|
Luke Timmerman |
10/28/09 |
Boston
|
|
Public Biotechs’ Finances Foundering, Epizyme Banks $32M, Paratek Cuts Deal with Novartis, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/09/09 |
Boston
|
|
The Boston Biotech Survival Index: Big Fish Still Swimming, Minnows Getting Eaten
|
Luke Timmerman |
10/08/09 |
Boston
|
|
Google Backs Adimab, PVI Sweetens E Ink Deal, Sanofi-Aventis Partners With Merrimack Pharma, & More Boston-Area Deals News
|
Rebecca Zacks |
10/02/09 |
Boston
|
|
Vertex Raises $155M Through Debt Financing for Hepatitis C Drug in Europe
|
Ryan McBride |
09/30/09 |
Boston
|
|
Anadys, Biotech’s Roller Coaster Story, Gears Up for Next Big Step with Hepatitis C Drug
|
Luke Timmerman |
08/19/09 |
San Diego
|
|
Domain Raises a $500M VC Fund, Dissident Prods Amylin Again, Avanir Passes Pivotal Test, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
08/13/09 |
San Diego
|
|
Seattle Genetics Recruits at Warp Speed, Amgen Passes Cancer Test, Stephen Friend’s Adventure & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/13/09 |
Seattle
|
|
Biogen Idec Faces Suit From Partner Elan, Genzyme Wins European Approval for Stem-Cell Boosting Drug, Alnylam Teams with Tekmira, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
08/12/09 |
Boston
|
|
Vertex Drug Could Be “Man on the Moon” for Cystic Fibrosis Therapy, Says Researcher Bonnie Ramsey
|
Luke Timmerman |
08/07/09 |
National
|
|
Biotech Startup Acetylon Pharma Catches $7.25M in A Round from Backers Such As New England Patriots Owner
|
Ryan McBride |
08/07/09 |
Boston
|
|
Genzyme Faces Lawsuit and Competition, Vertex Gathers More Cash for Telprevir, Cardiorobotics Corrals $11.6M, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
08/05/09 |
Boston
|
|
Vertex Scores $105M For Asian Telaprevir Rights, Avila Avails Itself of $30M, IBM Picks Up Ounce Labs, & More Boston-Area Deals News
|
Rebecca Zacks |
07/31/09 |
Boston
|
|
Vertex Grabs $105M in Amended Telaprevir Deal with Mitsubishi
|
Ryan McBride |
07/30/09 |
Boston
|
|
ConforMIS Corrals $50M, Oscient Files for Bankruptcy, Vertex Peddles Rights to Milestone Payments, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
07/15/09 |
Boston
|
|
Vertex Selling Telaprevir Payment Rights
|
Ryan McBride |
07/10/09 |
Boston
|
|
Dendreon Tames Short Sellers, Transforms Itself into Old-School Buy-and-Hold Stock
|
Luke Timmerman |
06/30/09 |
Seattle
|
|
Concert Pharma Jamming with Glaxo in Deal with $1B-Plus Potential
|
Ryan McBride |
06/02/09 |
Boston
|
|
Genentech Veteran Takes Agios’ Helm, E8 and MIT Take on Navigenics, Genzyme’s Mipomersen Takes Next Step, Alnylam Takes Advantage of Tekmira Technology, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
05/28/09 |
Boston
|
|
How to Raise $50M in a Recession: Highlights from the Xconomy Life Sciences Forum
|
Luke Timmerman |
05/01/09 |
Boston
|
|
Avila Therapeutics May Have Found “Achilles’ Heel” of Hepatitis C Virus
|
Ryan McBride |
04/27/09 |
Boston
|
|
Vertex’s Telaprevir Passes Test in Tough-To-Treat Hepatitis C Patients
|
Luke Timmerman |
04/25/09 |
Boston
|
|
Anadys Hepatitis C Drug Shows Potent Effect in Small Study
|
Luke Timmerman |
04/23/09 |
San Diego
|
|
Biotech Survival Index 2: Boston Life Sciences Companies Squirrel Away More Cash for Long Winter
|
Luke Timmerman |
03/17/09 |
Boston
|
|
Using HIV as Model, Anadys Develops Drug Cocktail Ingredient for Hepatitis C
|
Luke Timmerman |
03/17/09 |
San Diego
|
|
Biotechs Raise Capital, the Tale of Four Finns Who Helped Pioneer the Web Browser, Qualcomm Takes Another Step in Its Corporate Succession, & More SD BizTech News
|
Bruce V. Bigelow |
03/09/09 |
San Diego
|
|
Vertex Puts up $375M for ViroChem, Nuance Finally Nabs Zi, Proteon Procures $38M, & More Boston-Area Deals News
|
Rebecca Zacks |
03/06/09 |
Boston
|
|
Page 1 of
3 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
